PIPE-cloned recombinant human IgE, IgG1 and IgG4 antibodies against the major birch pollen allergen Bet v 1 in the PIPEline (2019)

First Author: Koehler V. K.

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 74

Parent Publication: ALLERGY

ISSN: 0105-4538